LYR-220 for Adult Subjects With Chronic Rhinosinusitis (BEACON Study)

NCT05035654 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Sinusitis
Chronic Rhinosinusitis (Diagnosis)

Interventions

DRUG: LYR-220 Design 1 (Part 1 only)
DRUG: LYR-220 Design 2 (Part 1 and Part 2)
DRUG: Bilateral sham procedure control (Part 2)

Sponsor

Lyra Therapeutics